Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CVSC This is what a lot of money will CVSC: Cardiovascular Sciences is an early-stage biotech company developing anti-adhesion products to eliminate the occurrence of adhesions after all types of surgeries. Post-surgical adhesions occur after more than 90% of surgical procedures, often with very painful and debilitating results. Products now in use are no more than 50% effective over good surgical technique alone, and they are exceedingly expensive and difficult to handle. The products the company is developing will be more cost-effective and easy-to-use, with a prototype proven to be significantly more effective in eliminating adhesions than those products currently being marketed.
Ask surgeries or medical specialists from major hospitals. Ask about the demand for this type of product and increasing importance. This information will overcome all doubts about CVSC. CVSC be worth much money because the demand for this type of product. Try to confirm what I'm saying now.
CVSC: Discuss the following pages:
http://www.incubator.ucf.edu/Incubationprogram/index.html
http://www.incubator.ucf.edu/clients/index.html
http://www.incubator.ucf.edu/clients/graduates.html
The first page shows the time until a company comes out of incubation Pogram graduate of UCF (36 months, maximum). On the second page, appears CVSC as a current client of UCF. On the third page, the companies have already completed their graduation. However, logic indicates that CVSC is close, very close, to finish the term. I think very soon, in early 2010 you must leave a notice on this subject, according to the deadlines that gives UCF. Moreover, I suggest that people are informed of the importance of today's post-surgical anti-adhesion materials . More and more are seen in large hospitals in the world. Stick manufacturers have a business with a fantastic future. These nonstick prevent further complications due to adhesions of tissues and may even save lives. The demand is increasing. Well, well, makes excellent nonstick CVSC postoperative patients. I think it's a gold mine which is currently unrecognized. I encourage people to ask about the importance of post-surgical anti-adhesion materials and learn to value CVSC.
The anti-material post-surgical adhesion are now essential, lifesaving, and the technology developed by CVSC is well advanced.
CVSC: Discuss the following pages:
http://www.incubator.ucf.edu/Incubationprogram/index.html
http://www.incubator.ucf.edu/clients/index.html
http://www.incubator.ucf.edu/clients/graduates.html
The first page shows the time until a company comes out of incubation Pogram graduate of UCF (36 months, maximum). On the second page, appears CVSC as a current client of UCF. On the third page, the companies have already completed their graduation. However, logic indicates that CVSC is close, very close, to finish the term. I think very soon, in early 2010 you must leave a notice on this subject, according to the deadlines that gives UCF. Moreover, I suggest that people are informed of the importance of today's post-surgical anti-adhesion materials . More and more are seen in large hospitals in the world. Stick manufacturers have a business with a fantastic future. These nonstick prevent further complications due to adhesions of tissues and may even save lives. The demand is increasing. Well, well, makes excellent nonstick CVSC postoperative patients. I think it's a gold mine which is currently unrecognized. I encourage people to ask about the importance of post-surgical anti-adhesion materials and learn to value CVSC.
The anti-material post-surgical adhesion are now essential, lifesaving, and the technology developed by CVSC is well advanced.
CVSC. Strong hands are testing the market. They try to pull a little CVSC price brought fear and buy them at a cheaper price. I think it is very clear. Do not fear the commission of these sales and purchases so ridiculous. I feel that at any time enter CVSC strongly. Also, I hope CVSC investors are not afraid and do not pull down the price. All this may be the beginning of a huge explosion nearby.
CVSC. Strong hands are testing the market. They try to pull a little CVSC price brought fear and buy them at a cheaper price. I think it is very clear. Do not fear the commission of these sales and purchases so ridiculous. I feel that at any time enter CVSC strongly. Also, I hope CVSC investors are not afraid and do not pull down the price. All this may be the beginning of a huge explosion nearby.
D&B and CVSC: Does anyone know the publication of D & B, the 1st day of January 2010: Report title: Sarnoff, Stanley J Endowment For Cardiovascular Science Inc from D & B?. Is available in "alacrastore. The price is well over $ 200. It appreciates a comment or rating.I wonder if is related or not CVSC
D&B and CVSC: Does anyone know the publication of D & B, the 1st day of January 2010: Report title: Sarnoff, Stanley J Endowment For Cardiovascular Science Inc from D & B?. Is available in "alacrastore. The price is well over $ 200. It appreciates a comment or rating.I wonder if is related or not CVSC
Cardiovascular Sciences, Inc. Cardiovascular Sciences Inc, (OTC: CSVC), is an R&D stage company with ongoing research in the department of Chemistry at the University of Central Florida. After probing several technologies, one area stood out and 18 months ago, a project was launched. This has already yielded a material that promises to greatly redu...ce the clinically significant morbidity of adhesions that occur following as many as half of all surgeries in both the medical and veterinary fields. The offices of the company currently are located in the Research Park and the company is enrolled in the High-Technology Incubator program at UCF.See MoreFebruary 9, 2009 at 1:14pm ·
written by CEO:
Cardiovascular Sciences, Inc. I want to welcome all of you who are visiting this page and encourage you to sign on as a fan. We are excited about having a Facebook entry and will certainly post new developments for the company as they occur. From time to time, we will also list some exclusive notices on our health related retail site at www.Rejuv...en8online.com.
We are still located in the Research Park at the University of Central Florida and are still an active client company of UCF's award winning Technology Incubator. We look forward to ramping back up to full speed our research and development efforts in the area of the prevention of post-surgical adhesions and will utilize our Facebook page and other means to keep everyone informed.
Thank you for your interest and I look forward to interacting with you through Facebook.
Larry Hooper, 2/12/ 2009 8:09
Letter to Obama, signed by Larry Hooper, along with the CEOs of the world's largest companies ( December 2009)
As CEOs of some of the world’s leading technology companies, we have an understanding of the economic
pain being felt today. We are also aware of the promise that lies across the horizon if we are strategic in
our planning. The solutions we offer below are aimed at moving us forward—towards success
CVSC: 10 April 2009
Revision in Authorized Shares
Current issued shares total: 16,964,134
Current share distribution among officers, directors and beneficial owners:
Individual Position
Shares Held % of Issued Shares
Eric Edelmann Executive business consultant 2,418,097 14.3%
Larry Hooper President, CEO and director 5,296,800 31.2%
Jevne Conover Director 3500 <0.1%
Sam Harder Director 3810 <0.1%
John Martin Director 50,500 0.3%
Jim Deinlein Consultant 2,108,200 12.4%
Lawrence H. Hooper, Jr., MD
CEO, Cardiovascular Sciences, Inc.
3251 Progress Dr., #A-107 ? Orlando, FL 32826 ? 407-208-9943 ? Fax: 407-207-7348
Cardiovascular Sciences, Inc. Cardiovascular Sciences Inc, (OTC: CSVC), is an R&D stage company with ongoing research in the department of Chemistry at the University of Central Florida. After probing several technologies, one area stood out and 18 months ago, a project was launched. This has already yielded a material that promises to greatly redu...ce the clinically significant morbidity of adhesions that occur following as many as half of all surgeries in both the medical and veterinary fields. The offices of the company currently are located in the Research Park and the company is enrolled in the High-Technology Incubator program at UCF.See MoreFebruary 9, 2009 at 1:14pm ·
written by CEO:
Cardiovascular Sciences, Inc. I want to welcome all of you who are visiting this page and encourage you to sign on as a fan. We are excited about having a Facebook entry and will certainly post new developments for the company as they occur. From time to time, we will also list some exclusive notices on our health related retail site at www.Rejuv...en8online.com.
We are still located in the Research Park at the University of Central Florida and are still an active client company of UCF's award winning Technology Incubator. We look forward to ramping back up to full speed our research and development efforts in the area of the prevention of post-surgical adhesions and will utilize our Facebook page and other means to keep everyone informed.
Thank you for your interest and I look forward to interacting with you through Facebook.
Larry Hooper, 2/12/ 2009 8:09
Letter to Obama, signed by Larry Hooper, along with the CEOs of the world's largest companies ( December 2009)
As CEOs of some of the world’s leading technology companies, we have an understanding of the economic
pain being felt today. We are also aware of the promise that lies across the horizon if we are strategic in
our planning. The solutions we offer below are aimed at moving us forward—towards success
CVSC: 10 April 2009
Revision in Authorized Shares
Current issued shares total: 16,964,134
Current share distribution among officers, directors and beneficial owners:
Individual Position
Shares Held % of Issued Shares
Eric Edelmann Executive business consultant 2,418,097 14.3%
Larry Hooper President, CEO and director 5,296,800 31.2%
Jevne Conover Director 3500 <0.1%
Sam Harder Director 3810 <0.1%
John Martin Director 50,500 0.3%
Jim Deinlein Consultant 2,108,200 12.4%
Lawrence H. Hooper, Jr., MD
CEO, Cardiovascular Sciences, Inc.
3251 Progress Dr., #A-107 ? Orlando, FL 32826 ? 407-208-9943 ? Fax: 407-207-7348
CVSC http://www.google.com/patents?vid=USPAT5891012&id=sqoWAAAAEBAJ&dq=patent:5891012
http://www.google.com/patents?vid=USPAT6149578&id=jz4FAAAAEBAJ&dq=patent:6149578
http://www.google.com/patents?vid=USPAT6190304&id=xjgFAAAAEBAJ&dq=patent:6190304
http://www.google.com/patents?vid=USPAT6228018&id=kN0FAAAAEBAJ&dq=patent:6228018
CVSC http://www.google.com/patents?vid=USPAT5891012&id=sqoWAAAAEBAJ&dq=patent:5891012
http://www.google.com/patents?vid=USPAT6149578&id=jz4FAAAAEBAJ&dq=patent:6149578
http://www.google.com/patents?vid=USPAT6190304&id=xjgFAAAAEBAJ&dq=patent:6190304
http://www.google.com/patents?vid=USPAT6228018&id=kN0FAAAAEBAJ&dq=patent:6228018
CVSC: CVSC is fully aware of the baby boomer market out there that continues to grow!
There will be 57.8 million baby boomers living in 2030 according to projections.
Many baby boomers will need orthopedic surgery.
A study by Exponent projected a 673-percent increase in knee replacement surgeries over the next 25 years. Primary or revision knee replacements are expected to balloon to more than 3.5 million by 2031!
CVSC knows that the currently available products on the market for adhesions are not sufficiently effective, and are difficult and very costly to use.
CVSC is developing products that will be markedly more effective at a lower cost, and will also provide easier handling for the surgeons.
CVSC owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia.
CVSC has the worldwide marketing and licensing rights for a patented process that provides a novel cardioplegia solution containing pyruvate for use in cardiopulmonary bypass surgery.
Administration of the cardiplegia solution during surgery has numerous beneficial effects: 1) It protects the heart from injury resulting from ischemia; 2) the heart exhibits rapid and robust recovery. This process can also be used during valve replacement and repairs of structural defects of the heart.
CVSC has also acquired the rights to develop and market four patented aortic pumping catheters: an Enhanced Intra-Aortic Balloon Catheter (EIABC), a Removable Left Ventricular Assist Device with an Aortic Support Apparatus, a Coronary Artery Counterpulsation Device and Method, and a Piston-action Intra-Aortic Coronary Assist Device. The new catheter designs overcome the inefficiencies of existing products in the market, and are designed to be application specific, thereby delivering the optimal performance for any given clinical setting.
Currently, there are more than 600,000 cardiac catheterization procedures performed annually in the United States. There are more than 2.5 million cardiac catheterization procedures performed annually and as many as twice that as a global total.
CVSC has sponsored research at the University of Central Florida (UCF) and previously at other institutions which indicates that CVSC is on the right path and progressing well.
CVSC and the University of Central Florida have entered into an agreement to research and develop post-surgical anti-adhesion materials. The principal investigator, Dr. Kevin Belfield, chairman of the Department of Chemistry, is leading a team to further develop the most effective and efficient anti-adhesion materials.
It is expected that the scope of this research will expand and broaden as CVSC continues to develop this technology.
CVSC and the University of Central Florida have produced a second-generation material with physical properties which appear to have exceeded the initially designed criteria. At surgery, this material is placed over and between areas likely to produce adhesions and are gradually degraded and resorbed by the body after the period in which adhesions are likely to occur, has passed.
CVSC's next phase in development will involve several areas of investigation. One will be to devise methods to manipulate the physical characteristics of the material in order to broaden the range of indications in which the material will be useful. A second will be to expand the animal trials beyond the proof-of-concept phase so that data can be gathered to support the requirements to bring this product to market, first in the veterinary arena and on to use in human clinical medicine.
(level2stockquotes.com)
http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/Sector%20Briefs/_BRIEF_lifescience_biotech.pdf
document created on 21 January 2010. How can someone think CVSC is dead. CVSC is very much alive. This is a few days ago. Another more. There are many evidences.
Cardiovascular Sciences Inc. (Other OTC: CVSC.PK) (PINK:CVSC) Stock Research Trends Targets and Technical Analysis - Penny stocks pink sheets stock exchange [en]
Tags: Cardiovascular Sciences Inc.,CVSC.PK,Other OTC: CVSC.PK,PINK:CVSC,CVSC,CVSC.PK Penny stocks pink sheets stock exchange,CVSC.PK stock analysis,CVSC.PK stock trends,CVSC.PK stock research,CVSC.PK technical analysis,CVSC.PK support levels,CVSC.PK resistance levels,CVSC.PK targets,CVSC.PK trend,CVSC.PK indicators,CVSC.PK fibonacci,CVSC.PK stock quote,CVSC.PK stock chart,CVSC.PK option strategies
Posted in January 31st, 2010
Today we will analyze the stock Cardiovascular Sciences Inc. (CVSC.PK) for internet stock trading in the PK stock market,
Stock Technical indicators to notice in Cardiovascular Sciences Inc. (CVSC.PK)
1- Last bearish trend was from 0.19 $ (1/27/2010) to 0.10 $ (1/28/2010) a 0.09 $ move 2- The current bullish trend started from 0.10 $ at 1/28/2010 and is currently trading at 0.12 $. 3- CVSC.PK current support level is at 0.10 which is the 0.00 % fibonacci retracement of the last 0.09 $ move.
4- CVSC.PK current resistance level is at 0.12 which is the 23.60 % fibonacci retracement of the last 0.09 $ move.
5- According to ADX Indicator, the trend is currently strong bullish, which is getting stronger.
Cardiovascular Sciences Inc. (CVSC.PK) Short term stock chart patterns for internet stock trading :
6- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Mid term stock chart patterns for internet stock trading :
7- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Long term stock chart patterns for internet stock trading :
8- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Stock Trading Conclusion:
Cardiovascular Sciences Inc. (CVSC.PK) was trading in a strong bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show no favorited direction,
recommend hold or waiting for entry .
Stock Resistance Levels : 0.121, 0.134, 0.145, 0.156, 0.190, 0.214, 0.246.
Stock Support levels : 0.115, 0.112, 0.110, 0.108, 0.100
This analysis I found on this website. I do not know the country. You can verify this by selecting the English version. Outside the U.S.A. There are analysts who are interested CVSC.http://cy.thestocksprofit.com/pink/cvsc-pk-cardiovascular-sciences-inc/
As you can see in my previous post, people from many parts of the world are increasingly interested CVSC. A month ago nobody talked of CVSC. Right now, today, there are analysts who are interested CVSC. That's very good for shareholders. More and more knowledge of CVSC. I think that all this will bring more people interested in CVSC. I also think that from now grow the potential of such share. But really, it's fantastic that CVSC interest to analysts elsewhere. Anyone who reads me can confirm that I have made a very timely proof of this
CVSC: Another interesting story that has as protagonists and CARDIOVASCULAR SCIENCES INC UCF. He also refers to the most recent projects at UCF.
http://www.chubbybrain.com/investors/universityofcentralfloridabusinessincubationprogram#top
Page 2
CVSC: Another interesting story that has as protagonists and CARDIOVASCULAR SCIENCES INC UCF. He also refers to the most recent projects at UCF.
http://www.chubbybrain.com/investors/universityofcentralfloridabusinessincubationprogram#top
page 2
CVSC http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/Sector%20Briefs/_BRIEF_lifescience_biotech.pdf
document created on 21 January 2010. How can someone think CVSC is dead. CVSC is very much alive. This is a few days ago. Another more. There are many evidences.
http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/bioOrlando/press%20kit/BiotechLife%20ScienceCompanies.pdf
http://www.bioorlando.com/Strengths/companyprofiles.shtml
CVSC http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/Sector%20Briefs/_BRIEF_lifescience_biotech.pdf
document created on 21 January 2010. How can someone think CVSC is dead. CVSC is very much alive. This is a few days ago. Another more. There are many evidences.
http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/bioOrlando/press%20kit/BiotechLife%20ScienceCompanies.pdf
http://www.bioorlando.com/Strengths/companyprofiles.shtml
CVSC: CVSC is fully aware of the baby boomer market out there that continues to grow!
There will be 57.8 million baby boomers living in 2030 according to projections.
Many baby boomers will need orthopedic surgery.
A study by Exponent projected a 673-percent increase in knee replacement surgeries over the next 25 years. Primary or revision knee replacements are expected to balloon to more than 3.5 million by 2031!
CVSC knows that the currently available products on the market for adhesions are not sufficiently effective, and are difficult and very costly to use.
CVSC is developing products that will be markedly more effective at a lower cost, and will also provide easier handling for the surgeons.
CVSC owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia.
CVSC has the worldwide marketing and licensing rights for a patented process that provides a novel cardioplegia solution containing pyruvate for use in cardiopulmonary bypass surgery.
Administration of the cardiplegia solution during surgery has numerous beneficial effects: 1) It protects the heart from injury resulting from ischemia; 2) the heart exhibits rapid and robust recovery. This process can also be used during valve replacement and repairs of structural defects of the heart.
CVSC has also acquired the rights to develop and market four patented aortic pumping catheters: an Enhanced Intra-Aortic Balloon Catheter (EIABC), a Removable Left Ventricular Assist Device with an Aortic Support Apparatus, a Coronary Artery Counterpulsation Device and Method, and a Piston-action Intra-Aortic Coronary Assist Device. The new catheter designs overcome the inefficiencies of existing products in the market, and are designed to be application specific, thereby delivering the optimal performance for any given clinical setting.
Currently, there are more than 600,000 cardiac catheterization procedures performed annually in the United States. There are more than 2.5 million cardiac catheterization procedures performed annually and as many as twice that as a global total.
CVSC has sponsored research at the University of Central Florida (UCF) and previously at other institutions which indicates that CVSC is on the right path and progressing well.
CVSC and the University of Central Florida have entered into an agreement to research and develop post-surgical anti-adhesion materials. The principal investigator, Dr. Kevin Belfield, chairman of the Department of Chemistry, is leading a team to further develop the most effective and efficient anti-adhesion materials.
It is expected that the scope of this research will expand and broaden as CVSC continues to develop this technology.
CVSC and the University of Central Florida have produced a second-generation material with physical properties which appear to have exceeded the initially designed criteria. At surgery, this material is placed over and between areas likely to produce adhesions and are gradually degraded and resorbed by the body after the period in which adhesions are likely to occur, has passed.
CVSC's next phase in development will involve several areas of investigation. One will be to devise methods to manipulate the physical characteristics of the material in order to broaden the range of indications in which the material will be useful. A second will be to expand the animal trials beyond the proof-of-concept phase so that data can be gathered to support the requirements to bring this product to market, first in the veterinary arena and on to use in human clinical medicine.
(level2stockquotes.com)
CVSC: CVSC is fully aware of the baby boomer market out there that continues to grow!
There will be 57.8 million baby boomers living in 2030 according to projections.
Many baby boomers will need orthopedic surgery.
A study by Exponent projected a 673-percent increase in knee replacement surgeries over the next 25 years. Primary or revision knee replacements are expected to balloon to more than 3.5 million by 2031!
CVSC knows that the currently available products on the market for adhesions are not sufficiently effective, and are difficult and very costly to use.
CVSC is developing products that will be markedly more effective at a lower cost, and will also provide easier handling for the surgeons.
CVSC owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia.
CVSC has the worldwide marketing and licensing rights for a patented process that provides a novel cardioplegia solution containing pyruvate for use in cardiopulmonary bypass surgery.
Administration of the cardiplegia solution during surgery has numerous beneficial effects: 1) It protects the heart from injury resulting from ischemia; 2) the heart exhibits rapid and robust recovery. This process can also be used during valve replacement and repairs of structural defects of the heart.
CVSC has also acquired the rights to develop and market four patented aortic pumping catheters: an Enhanced Intra-Aortic Balloon Catheter (EIABC), a Removable Left Ventricular Assist Device with an Aortic Support Apparatus, a Coronary Artery Counterpulsation Device and Method, and a Piston-action Intra-Aortic Coronary Assist Device. The new catheter designs overcome the inefficiencies of existing products in the market, and are designed to be application specific, thereby delivering the optimal performance for any given clinical setting.
Currently, there are more than 600,000 cardiac catheterization procedures performed annually in the United States. There are more than 2.5 million cardiac catheterization procedures performed annually and as many as twice that as a global total.
CVSC has sponsored research at the University of Central Florida (UCF) and previously at other institutions which indicates that CVSC is on the right path and progressing well.
CVSC and the University of Central Florida have entered into an agreement to research and develop post-surgical anti-adhesion materials. The principal investigator, Dr. Kevin Belfield, chairman of the Department of Chemistry, is leading a team to further develop the most effective and efficient anti-adhesion materials.
It is expected that the scope of this research will expand and broaden as CVSC continues to develop this technology.
CVSC and the University of Central Florida have produced a second-generation material with physical properties which appear to have exceeded the initially designed criteria. At surgery, this material is placed over and between areas likely to produce adhesions and are gradually degraded and resorbed by the body after the period in which adhesions are likely to occur, has passed.
CVSC's next phase in development will involve several areas of investigation. One will be to devise methods to manipulate the physical characteristics of the material in order to broaden the range of indications in which the material will be useful. A second will be to expand the animal trials beyond the proof-of-concept phase so that data can be gathered to support the requirements to bring this product to market, first in the veterinary arena and on to use in human clinical medicine.
(level2stockquotes.com)
CVSC http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/Sector%20Briefs/_BRIEF_lifescience_biotech.pdf
document created on 21 January 2010. How can someone think CVSC is dead?. CVSC is very much alive. This is a few days ago. Another more. There are many evidences.
http://www.orlandoedc.com/core/file.php?loc=/Solodev/clients/solodev/Enterprise%20Main/Documents/EDC%20Documents/Sector%20Briefs/_BRIEF_lifescience_biotech.pdf
document created on 21 January 2010. How can someone think CVSC is dead. CVSC is very much alive. This is a few days ago. Another more. There are many evidences.
Cardiovascular Sciences Inc. (Other OTC: CVSC.PK) (PINK:CVSC) Stock Research Trends Targets and Technical Analysis - Penny stocks pink sheets stock exchange [en]
Tags: Cardiovascular Sciences Inc.,CVSC.PK,Other OTC: CVSC.PK,PINK:CVSC,CVSC,CVSC.PK Penny stocks pink sheets stock exchange,CVSC.PK stock analysis,CVSC.PK stock trends,CVSC.PK stock research,CVSC.PK technical analysis,CVSC.PK support levels,CVSC.PK resistance levels,CVSC.PK targets,CVSC.PK trend,CVSC.PK indicators,CVSC.PK fibonacci,CVSC.PK stock quote,CVSC.PK stock chart,CVSC.PK option strategies
Posted in January 31st, 2010
Today we will analyze the stock Cardiovascular Sciences Inc. (CVSC.PK) for internet stock trading in the PK stock market,
Stock Technical indicators to notice in Cardiovascular Sciences Inc. (CVSC.PK)
1- Last bearish trend was from 0.19 $ (1/27/2010) to 0.10 $ (1/28/2010) a 0.09 $ move 2- The current bullish trend started from 0.10 $ at 1/28/2010 and is currently trading at 0.12 $. 3- CVSC.PK current support level is at 0.10 which is the 0.00 % fibonacci retracement of the last 0.09 $ move.
4- CVSC.PK current resistance level is at 0.12 which is the 23.60 % fibonacci retracement of the last 0.09 $ move.
5- According to ADX Indicator, the trend is currently strong bullish, which is getting stronger.
Cardiovascular Sciences Inc. (CVSC.PK) Short term stock chart patterns for internet stock trading :
6- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Mid term stock chart patterns for internet stock trading :
7- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Long term stock chart patterns for internet stock trading :
8- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Stock Trading Conclusion:
Cardiovascular Sciences Inc. (CVSC.PK) was trading in a strong bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show no favorited direction,
recommend hold or waiting for entry .
Stock Resistance Levels : 0.121, 0.134, 0.145, 0.156, 0.190, 0.214, 0.246.
Stock Support levels : 0.115, 0.112, 0.110, 0.108, 0.100
This analysis I found on this website. I do not know the country. You can verify this by selecting the English version. Outside the U.S.A. There are analysts who are interested CVSC.http://cy.thestocksprofit.com/pink/cvsc-pk-cardiovascular-sciences-inc/
As you can see in my previous post, people from many parts of the world are increasingly interested CVSC. A month ago nobody talked of CVSC. Right now, today, there are analysts who are interested CVSC. That's very good for shareholders. More and more knowledge of CVSC. I think that all this will bring more people interested in CVSC. I also think that from now grow the potential of such share. But really, it's fantastic that CVSC interest to analysts elsewhere. Anyone who reads me can confirm that I have made a very timely proof of this
Cardiovascular Sciences Inc. (Other OTC: CVSC.PK) (PINK:CVSC) Stock Research Trends Targets and Technical Analysis - Penny stocks pink sheets stock exchange [en]
Tags: Cardiovascular Sciences Inc.,CVSC.PK,Other OTC: CVSC.PK,PINK:CVSC,CVSC,CVSC.PK Penny stocks pink sheets stock exchange,CVSC.PK stock analysis,CVSC.PK stock trends,CVSC.PK stock research,CVSC.PK technical analysis,CVSC.PK support levels,CVSC.PK resistance levels,CVSC.PK targets,CVSC.PK trend,CVSC.PK indicators,CVSC.PK fibonacci,CVSC.PK stock quote,CVSC.PK stock chart,CVSC.PK option strategies
Posted in January 31st, 2010
Today we will analyze the stock Cardiovascular Sciences Inc. (CVSC.PK) for internet stock trading in the PK stock market,
Stock Technical indicators to notice in Cardiovascular Sciences Inc. (CVSC.PK)
1- Last bearish trend was from 0.19 $ (1/27/2010) to 0.10 $ (1/28/2010) a 0.09 $ move 2- The current bullish trend started from 0.10 $ at 1/28/2010 and is currently trading at 0.12 $. 3- CVSC.PK current support level is at 0.10 which is the 0.00 % fibonacci retracement of the last 0.09 $ move.
4- CVSC.PK current resistance level is at 0.12 which is the 23.60 % fibonacci retracement of the last 0.09 $ move.
5- According to ADX Indicator, the trend is currently strong bullish, which is getting stronger.
Cardiovascular Sciences Inc. (CVSC.PK) Short term stock chart patterns for internet stock trading :
6- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Mid term stock chart patterns for internet stock trading :
7- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Long term stock chart patterns for internet stock trading :
8- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Stock Trading Conclusion:
Cardiovascular Sciences Inc. (CVSC.PK) was trading in a strong bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show no favorited direction,
recommend hold or waiting for entry .
Stock Resistance Levels : 0.121, 0.134, 0.145, 0.156, 0.190, 0.214, 0.246.
Stock Support levels : 0.115, 0.112, 0.110, 0.108, 0.100
This analysis I found on this website. I do not know the country. You can verify this by selecting the English version. Outside the U.S.A. There are analysts who are interested CVSC.http://cy.thestocksprofit.com/pink/cvsc-pk-cardiovascular-sciences-inc/
As you can see in my previous post, people from many parts of the world are increasingly interested CVSC. A month ago nobody talked of CVSC. Right now, today, there are analysts who are interested CVSC. That's very good for shareholders. More and more knowledge of CVSC. I think that all this will bring more people interested in CVSC. I also think that from now grow the potential of such share. But really, it's fantastic that CVSC interest to analysts elsewhere. Anyone who reads me can confirm that I have made a very timely proof of this.
Finally, I think there are reasons to be calm within CVSC. The management team has most of the common shares. There is no argument to doubt CVSC. I think the opposite: many reports have been unearthed today, all positive. No negative information. You just have to wait for economic performance. CVSC no obligation to publish them, because a company is classified as "no information". But I expect those results to the spring, in March. For the moment, has already sparked CVSC. Many people believed there was no current information CVSC, has found that it had information. Information that has been unearthed. But diamonds are also buried.
As you can see in my previous post, people from many parts of the world are increasingly interested CVSC. A month ago nobody talked of CVSC. Right now, today, there are analysts who are interested CVSC. That's very good for shareholders. More and more knowledge of CVSC. I think that all this will bring more people interested in CVSC. I also think that from now grow the potential of such share. But really, it's fantastic that CVSC interest to analysts elsewhere. Anyone who reads me can confirm that I have made a very timely proof of this.
Cardiovascular Sciences Inc. (Other OTC: CVSC.PK) (PINK:CVSC) Stock Research Trends Targets and Technical Analysis - Penny stocks pink sheets stock exchange [en]
Tags: Cardiovascular Sciences Inc.,CVSC.PK,Other OTC: CVSC.PK,PINK:CVSC,CVSC,CVSC.PK Penny stocks pink sheets stock exchange,CVSC.PK stock analysis,CVSC.PK stock trends,CVSC.PK stock research,CVSC.PK technical analysis,CVSC.PK support levels,CVSC.PK resistance levels,CVSC.PK targets,CVSC.PK trend,CVSC.PK indicators,CVSC.PK fibonacci,CVSC.PK stock quote,CVSC.PK stock chart,CVSC.PK option strategies
Posted in January 31st, 2010
Today we will analyze the stock Cardiovascular Sciences Inc. (CVSC.PK) for internet stock trading in the PK stock market,
Stock Technical indicators to notice in Cardiovascular Sciences Inc. (CVSC.PK)
1- Last bearish trend was from 0.19 $ (1/27/2010) to 0.10 $ (1/28/2010) a 0.09 $ move 2- The current bullish trend started from 0.10 $ at 1/28/2010 and is currently trading at 0.12 $. 3- CVSC.PK current support level is at 0.10 which is the 0.00 % fibonacci retracement of the last 0.09 $ move.
4- CVSC.PK current resistance level is at 0.12 which is the 23.60 % fibonacci retracement of the last 0.09 $ move.
5- According to ADX Indicator, the trend is currently strong bullish, which is getting stronger.
Cardiovascular Sciences Inc. (CVSC.PK) Short term stock chart patterns for internet stock trading :
6- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Mid term stock chart patterns for internet stock trading :
7- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Cardiovascular Sciences Inc. (CVSC.PK) Long term stock chart patterns for internet stock trading :
8- The Stock traded in a bullish stock channel identifed by support at 0.100 and 0.050,resistance between 0.190 and 0.100, the stock channel is currently supported from below by 0.113 and resisted from above by 0.220.
Stock Trading Conclusion:
Cardiovascular Sciences Inc. (CVSC.PK) was trading in a strong bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show no favorited direction,
recommend hold or waiting for entry .
Stock Resistance Levels : 0.121, 0.134, 0.145, 0.156, 0.190, 0.214, 0.246.
Stock Support levels : 0.115, 0.112, 0.110, 0.108, 0.100
This analysis I found on this website. I do not know the country. You can verify this by selecting the English version. Outside the U.S.A. There are analysts who are interested CVSC.http://cy.thestocksprofit.com/pink/cvsc-pk-cardiovascular-sciences-inc/
Most likely you soon CVSC report its financial results during the second half of 2009. I do not believe to be negative, but nobody knows yet how they will be. I hope to be quite acceptable. But I do not care that much. I care more CVSC connections with other institutions such as UCF and, through its CEO, the connection with BioTechMedicalSoftware. I appreciate also the high value of their 4 patents. If CVSC was in great difficulty (which I doubt), could sell any of its patents and get a big win, because big companies really interested in them. But CVSC had no need of it. It is a fact that 90% of companies that are in the UCF program, succeed(according claim Oneal)
What I say I base it on documentation. No documentation for what you are saying. There is no news published about it. Perhaps you want to do harm, just that. Now I bring another element: market studies of post-surgical non-stick. CVSC appears. CVSC has advanced technology in this field. Something like that never breaks, why?. Simply, all surgery professionals know the importance of this type. Simply CVSC patents worth a fortune. Any intelligent and informed person should know that. Here are the links that prove my point:
http://www.mediligence.com/rpt/rpt-s175.htm
http://www.prlog.org/10172620-growing-caseload-applications-active-companies-and-markets-in-sealantsglues-wound-closure-market.html
The study referred to a market survey for the years 2009 to 2013. Check that is CVSC
CVSC 0.2000 +0.1000 (50.00 %)
CVSC CARDIOVASCULAR SCIENCES INC COM
Bid: N/A Ask: N/A
Volume: 114904 Market: OTC
Quote as of 10:38 ET
Yesterday we wanted to frighten, but CVSC is up. We do not go, we endure, we gain a lot.
CVSC 0.2000 +0.1000 (50.00 %)
CVSC CARDIOVASCULAR SCIENCES INC COM
Bid: N/A Ask: N/A
Volume: 114904 Market: OTC
Quote as of 10:38 ET
Yesterday we wanted to frighten, but CVSC is up. We do not go, we endure, we gain a lot.
CVSC comes, it comes up. Whoever enters the pockets are CVSC. Is the best way to be made rich. GOOOOOOOOOOOOOOOOO CVSC
CVSC comes, it comes up. Whoever enters the pockets are CVSC. Is the best way to be made rich. GOOOOOOOOOOOOOOOOO CVSC
CVSC
0.1900 +0.0900 (47.37 %)
CVSC CARDIOVASCULAR SCIENCES INC COM
Bid: N/A Ask: N/A
Volume: 68520 Market: OTC
0.1650 +0.0650 (39.39 %)
CVSC CARDIOVASCULAR SCIENCES INC COM
Bid: N/A Ask: N/A
Volume: 43020 Market: OTC
Quote as of 10:05 ET